BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37694076)

  • 1. Serum and Saliva LDH Levels in Patients with Habit, Oral Potentially Malignant Disorders (OPMDs), and Oral Squamous Cell Carcinoma (OSCC): A Spectrophotometry Study.
    Shah FY; Shetty DC; Kaur G; Gupta S; Pathak A; Aggarwal V
    J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S881-S884. PubMed ID: 37694076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity.
    Javaraiah RK; David CM; Namitha J; Tiwari R; Benakanal P
    South Asian J Cancer; 2020 Jun; 9(2):93-98. PubMed ID: 33354552
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimation of salivary lactate dehydrogenase in oral squamous cell carcinoma, oral leukoplakia, and smokers.
    Bhuvaneswari M; Prasad H; Rajmohan M; Sri Chinthu KK; Prema P; Mahalakshmi L; Kumar GS
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S215-S218. PubMed ID: 36510967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.
    Saluja TS; Spadigam A; Dhupar A; Syed S
    Tumour Biol; 2016 Apr; 37(4):5609-20. PubMed ID: 26577856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma.
    Daniel D; Jose J; Harish Kumar A
    J Maxillofac Oral Surg; 2021 Mar; 20(1):83-89. PubMed ID: 33584047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric analysis of basal cells of oral epithelium in predicting malignant transformation of oral potentially malignant disorders in patients with tobacco chewing habit.
    Santoshi CK; Kumar JV; Bhagirath PV; Vinay BH; Prakash YJ
    J Oral Maxillofac Pathol; 2020; 24(3):579. PubMed ID: 33967506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
    Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
    Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
    Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
    J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.
    Anitha G; Kumar KV; Deshpande G; Nagaraj M; Kalyani V
    J Oral Maxillofac Pathol; 2022; 26(2):218-227. PubMed ID: 35968187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant-Oxidant Index as a Biomarker in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Biochemical Study.
    Juneja S; Rathore AS; Sharma K; Shetty D; Jain A
    J Clin Diagn Res; 2017 Mar; 11(3):ZC05-ZC08. PubMed ID: 28511498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Mast Cells in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Shrestha A; Keshwar S; Raut T
    Int J Dent; 2021; 2021():5609563. PubMed ID: 34490052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
    Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
    Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
    Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
    Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
    Lorini L; Tomasoni M; Gurizzan C; Magri C; Facchetti M; Battocchio S; Romani C; Ravanelli M; Oberti A; Bozzola A; Bardellini E; Paderno A; Mattavelli D; Lombardi D; Grammatica A; Deganello A; Facchetti F; Calza S; Majorana A; Piazza C; Bossi P
    Front Oncol; 2022; 12():886404. PubMed ID: 35530364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
    Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
    Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study.
    D'Cruz AM; Pathiyil V
    South Asian J Cancer; 2015; 4(2):58-60. PubMed ID: 25992341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.